Literature DB >> 3117034

Development of multiple activities of UDP-glucuronyltransferase in human liver.

J E Leakey1, R Hume, B Burchell.   

Abstract

UDP-glucuronyltransferase activities towards eight substrates were assayed in samples of foetal, term and adult human liver. Activities towards bilirubin, androsterone, testosterone, 1-naphthol, 4-nitrophenol and 2-aminophenol were present in foetal and term liver samples at less than 14% of adult values, whereas activity towards 5-hydroxytryptamine was present in foetal and term liver at 109 and 121% of adult values respectively. Thus a 'foetal' form of UDP-glucuronyltransferase may exist in human liver that is more restricted in substrate specificity than are those of the rat or rhesus monkey.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117034      PMCID: PMC1147936          DOI: 10.1042/bj2430859

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Functional heterogeneity of UDP-glucuronosyltransferase as indicated by its differential development and inducibility by glucocorticoids. Demonstration of two groups within the enzyme's activity towards twelve substrates.

Authors:  G J Wishart
Journal:  Biochem J       Date:  1978-08-15       Impact factor: 3.857

2.  UDP-glucuronyltransferase in perfused rat liver and in microsomes - III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin.

Authors:  G Otani; M M Abou-El-Makarem; K W Bock
Journal:  Biochem Pharmacol       Date:  1976-06-01       Impact factor: 5.858

3.  An improved assay for steroid glucuronyltransferase in rat liver microsomes.

Authors:  G S Rao; G Haueter; M L Rao; H Breuer
Journal:  Anal Biochem       Date:  1976-07       Impact factor: 3.365

4.  Isolation and purification of bilirubin UDP-glucuronyl-transferase from rat liver.

Authors:  B Burchell
Journal:  FEBS Lett       Date:  1980-02-25       Impact factor: 4.124

5.  An improved assay technique for uridine diphosphate glucuronosyltransferase activity towards 5-hydroxytryptamine and some properties of the enzyme.

Authors:  J E Leakey
Journal:  Biochem J       Date:  1978-12-01       Impact factor: 3.857

6.  Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver.

Authors:  S Onishi; N Kawade; S Itoh; K Isobe; S Sugiyama
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

7.  Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.

Authors:  L von Meyerinck; B L Coffman; M D Green; R B Kirkpatrick; A Schmoldt; T R Tephly
Journal:  Drug Metab Dispos       Date:  1985 Nov-Dec       Impact factor: 3.922

8.  Determination of bilirubin glucuronide and assay of glucuronyltransferase with bilirubin as acceptor.

Authors:  F P Van Roy; K P Heirwegh
Journal:  Biochem J       Date:  1968-04       Impact factor: 3.857

9.  Steroid and non-steroid UDP glucuronyltransferase: glucuronidation of synthetic estrogens as steroids.

Authors:  G W Lucier; O S McDaniel
Journal:  J Steroid Biochem       Date:  1977-08       Impact factor: 4.292

10.  Detection, purification and characterization of a human cancer-associated galactosyltransferase acceptor.

Authors:  D K Podolsky; M M Weiser
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

View more
  25 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  Uridine 5'-diphosphoglucuronic acid (UDPGLcUA) in the human fetal liver, kidney and placenta.

Authors:  M Cappiello; L Giuliani; A Rane; G M Pacifici
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Jul-Dec       Impact factor: 2.441

Review 3.  Fetal drug metabolism and its possible clinical implications.

Authors:  B Krauer; P Dayer
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

4.  Immunochemical analysis of uridine diphosphate-glucuronosyltransferase in four patients with the Crigler-Najjar syndrome type I.

Authors:  H H van Es; B G Goldhoorn; M Paul-Abrahamse; R P Elferink; P L Jansen
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Genetic variation, expression and ontogeny of sulfotransferase SULT2A1 in humans.

Authors:  L Ekström; A Rane
Journal:  Pharmacogenomics J       Date:  2015-03-24       Impact factor: 3.550

6.  Induction of bilirubin clearance by the constitutive androstane receptor (CAR).

Authors:  Wendong Huang; Jun Zhang; Steven S Chua; Mohammed Qatanani; Yunqing Han; Riccarda Granata; David D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

7.  Sulphation and glucuronidation of ritodrine in human foetal and adult tissues.

Authors:  G M Pacifici; M Kubrich; L Giuliani; M de Vries; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Differential localisation of UDP-glucuronosyltransferase in kidney during human embryonic and fetal development.

Authors:  R Hume; M W Coughtrie; B Burchell
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

Review 9.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants.

Authors:  Antonia M Calafat; Jennifer Weuve; Xiaoyun Ye; Lily T Jia; Howard Hu; Steven Ringer; Ken Huttner; Russ Hauser
Journal:  Environ Health Perspect       Date:  2008-12-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.